PRISM MarketView Highlights Soligenix's Promising HyBryte™ Replication Trial

Soligenix

Soligenix is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need

Format

JPEG

Source

PRISM MarketView

Downloads